227 related articles for article (PubMed ID: 16956368)
1. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.
Holbourn KP; Shone CC; Acharya KR
FEBS J; 2006 Oct; 273(20):4579-93. PubMed ID: 16956368
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
3. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions.
de Souza RF; Aravind L
Mol Biosyst; 2012 Jun; 8(6):1661-77. PubMed ID: 22399070
[TBL] [Abstract][Full Text] [Related]
5. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
Han S; Tainer JA
Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
[TBL] [Abstract][Full Text] [Related]
6. The best defense is a good offense--Salmonella deploys an ADP-ribosylating toxin.
Lesnick ML; Guiney DG
Trends Microbiol; 2001 Jan; 9(1):2-4; discussion 4-5. PubMed ID: 11166220
[TBL] [Abstract][Full Text] [Related]
7. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.
Han S; Craig JA; Putnam CD; Carozzi NB; Tainer JA
Nat Struct Biol; 1999 Oct; 6(10):932-6. PubMed ID: 10504727
[TBL] [Abstract][Full Text] [Related]
8. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
Vogelsgesang M; Aktories K
Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
[TBL] [Abstract][Full Text] [Related]
9. Substrate binding and catalysis of ecto-ADP-ribosyltransferase 2.2 from rat.
Ritter H; Koch-Nolte F; Marquez VE; Schulz GE
Biochemistry; 2003 Sep; 42(34):10155-62. PubMed ID: 12939142
[TBL] [Abstract][Full Text] [Related]
10. Rho-modifying C3-like ADP-ribosyltransferases.
Aktories K; Wilde C; Vogelsgesang M
Rev Physiol Biochem Pharmacol; 2004; 152():1-22. PubMed ID: 15372308
[TBL] [Abstract][Full Text] [Related]
11. The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs.
Barth H; Blöcker D; Aktories K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):501-12. PubMed ID: 12444490
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the Clostridium limosum C3 exoenzyme.
Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the RNA 2'-phosphotransferase from Aeropyrum pernix K1.
Kato-Murayama M; Bessho Y; Shirouzu M; Yokoyama S
J Mol Biol; 2005 Apr; 348(2):295-305. PubMed ID: 15811369
[TBL] [Abstract][Full Text] [Related]
14. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.
Wilde C; Vogelsgesang M; Aktories K
Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311
[TBL] [Abstract][Full Text] [Related]
15. In silico identification of novel bacterial ADP-ribosyltransferases.
Masignani V; Balducci E; Serruto D; Veggi D; Aricò B; Comanducci M; Pizza M; Rappuoli R
Int J Med Microbiol; 2004 Apr; 293(7-8):471-8. PubMed ID: 15149020
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling and molecular dynamics studies of a novel C3-like ADP-ribosyltransferase.
Xiao JF; Li ZS; Sun CC
Bioorg Med Chem; 2004 May; 12(9):2035-41. PubMed ID: 15080907
[TBL] [Abstract][Full Text] [Related]
17. Endogenous relatives of ADP-ribosylating bacterial toxins in mice and men: potential regulators of immune cell function.
Haag F; Koch-Nolte F
J Biol Regul Homeost Agents; 1998; 12(3):53-62. PubMed ID: 9795832
[TBL] [Abstract][Full Text] [Related]
18. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
Domenighini M; Magagnoli C; Pizza M; Rappuoli R
Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
[TBL] [Abstract][Full Text] [Related]
19. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
Parikh SL; Schramm VL
Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
[TBL] [Abstract][Full Text] [Related]
20. Detection of ADP-Ribosylating Bacterial Toxins.
Chen C; Barbieri JT
Methods Mol Biol; 2018; 1813():287-295. PubMed ID: 30097876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
